Ferroptosis

铁死亡 (Ferroptosis) 是一种非凋亡形式的受控细胞死亡。它不同于其他受控细胞死亡表型,例如凋亡和坏死性凋亡。铁死亡的特征是广泛的脂质过氧化,可以通过铁螯合剂或亲脂性抗氧化剂抑制。从机制上讲,铁死亡诱导剂分为两类:(1) 通过 xc− 系统抑制胱氨酸输入的抑制剂(例如 Erastin),随后导致谷胱甘肽 (GSH) 消耗;(2) 谷胱甘肽过氧化物酶 4 (GPX4) 的共价抑制剂(例如 (1S, 3R)-RSL3)。由于 GPX4 使用 GSH 作为共底物来还原脂质氢过氧化物,因此这两类化合物最终都会导致 GPX4 活性丧失,随后脂质活性氧 (ROS) 水平升高,从而导致细胞死亡。

铁死亡是一种依赖铁和 ROS 的受控细胞死亡 (RCD)。失调的铁死亡与多种生理和病理过程有关,包括癌细胞死亡、神经毒性、神经退行性疾病、急性肾衰竭、药物引起的肝毒性、肝脏和心脏缺血/再灌注损伤以及 T 细胞免疫。

Ferroptosis is a non-apoptotic form of regulated cell death. It is distinct from other regulated cell death phenotypes, such as apoptosis and necroptosis. Ferroptosis is characterized by extensive lipid peroxidation, which can be suppressed by iron chelators or lipophilic antioxidants. Mechanistically, Ferroptosis inducers are divided into two classes: (1) inhibitors of cystine import via system xc− (e.g., Erastin), which subsequently causes depletion of glutathione (GSH), and (2) covalent inhibitors (e.g., (1S, 3R)-RSL3) of glutathione peroxidase 4 (GPX4). Since GPX4 reduces lipid hydroperoxides using GSH as a co-substrate, both compound classes ultimately result in loss of GPX4 activity, followed by elevated levels of lipid reactive oxygen species (ROS) and consequent cell death.

Ferroptosis is an iron- and ROS-dependent form of regulated cell death (RCD). Misregulated Ferroptosis has been implicated in multiple physiological and pathological processes, including cancer cell death, neurotoxicity, neurodegenerative diseases, acute renal failure, drug-induced hepatotoxicity, hepatic and heart ischemia/reperfusion injury, and T-cell immunity.

共 5种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
(1R,3R)-Ferroptosis inducer-1

(1R,3R)-Ferroptosis inducer-1 (compound BX-3a) 是铁死亡的诱导剂,而 (1R,3R)-Ferroptosis 是 Ferroptosis inducer-1 (MS-D28010) 的异构体。

2375357-97-2
Control
99.34%
(1R,3R)-Ferroptosis inducer-1
(1R,3R)-RSL3

(1R,3R)-RSL3 是 RSL3 (MS-V15144) 的异构体,而 RSL3 ((1S,3R)-RSL3) 是一种谷胱甘肽过氧化物酶 4 (GPX4) 抑制剂(ferroptosis 激动剂),可降低 GPX4 表达并诱导头颈部癌细胞肥大性死亡,在 HN3 耐受细胞中还可增加 p62 和 Nrf2 的蛋白水平并使 Keap1 灭活。

1219810-15-7
Control
99.05%
(1R,3R)-RSL3
(1R,3R)-RSL3 (Standard)

(1R,3R)-RSL3 (Standard) 是 (1R,3R)-RSL3 (MS-V13712) 的分析标准品,用于研究及分析应用;(1R,3R)-RSL3 是 RSL3 (MS-V15144) 的异构体,而 RSL3 ((1S,3R)-RSL3) 是一种谷胱甘肽过氧化物酶 4 (GPX4) 抑制剂(ferroptosis 激动剂),可降低 GPX4 的表达并诱导头颈部癌细胞的肥大性死亡,在 HN3 耐受细胞中可增加 p62 和 Nrf2 的蛋白水平,使 Kea

1219810-15-7
Control
(1R,3R)-RSL3 (Standard)
(1R,3S)-RSL3

(1R,3S)-RSL3 是 RSL3 ((1S,3R)-RSL3) 的活性较低的 (1R,3S)-对映体,二者均可诱导 HT22 野生型细胞死亡,EC50 值分别为 5.2 µM 和 0.004 µM。

1219810-13-5
Control
99.78%
(1R,3S)-RSL3
SP 600125, negative control
JNK Inhibitor II, negative control

SP 600125, negative control (SPM1) 是一种吡唑蒽酮的烷基衍生物,可作为 SP600125 (MS-X95304) 的阴性对照。

54642-23-8
Control
98.05%
SP 600125, negative control

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础